Alto Neuroscience, Inc. (ANRO) — Financial Flexibility Index
Alto Neuroscience, Inc. (ANRO) has a Financial Flexibility Index of -0.34x as of December 2025. Free cash flow of $-11.52 Million (operating CF $-11.52 Million minus capex $0.00) represents 0% of total liabilities ($33.55 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alto Neuroscience, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Alto Neuroscience, Inc. across 5 annual periods. See Alto Neuroscience, Inc. (ANRO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Alto Neuroscience, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Alto Neuroscience, Inc.. For the full company profile including market capitalisation, see Alto Neuroscience, Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.54x | $-51.74 Million | $-51.77 Million | $33.55 Million | ▲ +11.3% |
| 2024 | -1.74x | $-45.35 Million | $-47.42 Million | $26.08 Million | ▼ -734.6% |
| 2023 | -0.21x | $-32.98 Million | $-33.45 Million | $158.30 Million | ▲ +5.4% |
| 2022 | -0.22x | $-19.66 Million | $-20.39 Million | $89.26 Million | ▼ -5.9% |
| 2021 | -0.21x | $-8.58 Million | $-9.26 Million | $41.27 Million | — |